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Early Descriptions of Possible Angina Pectoris
Notwithstanding the conditions prevailing before the eighteenth century, there
were undoubtedly some few individuals who had the potential for development of
ischaemic heart disease. This can occur in the absence ofexogenous risk factors for
coronary arteriosclerosis, for example, in rare homozygous subjects with familial
abnormalities of cholesterol metabolism.3 Congenital coronary arterial anomalies
can also very occasionally cause angina independently of arteriosclerotic disease.4
Either of these could have accounted for Heberden's twelve-year-old patient with
exertional chest pain. The present work does not therefore attempt to prove that
angina pectoris was a totally new syndrome emerging in the mid-eighteenth century
in the way, for example, that Acquired Immune Deficiency Syndrome (AIDS) first
became manifest in the late 1970s. It isbeing suggested thatbefore themid-eighteenth
century angina pectoris was too rare to have been recognisable as a distinct clinical
entity by any one physician.
3 Peter H Jones and Antonio M Gotto, 'Assessment of lipid abnormalities in the heart', in J Willis
Hurst and Richard C Schlant (eds), The heart, arteries and veins, 7th ed., New York, McGraw Hill, 1990,
p. 378.
4J Noble et at., 'Myocardial bridging and milking effect of the left anterior coronary artery. Normal
variant or obstruction?', Am J Cardiol. 1976. 37: 993-9. p. 997.
Coronary Heart Disease Frequency in the Absence of Traditional Risk Factors
In mid-twentieth century studies, the frequency of symptomatic coronary heart
disease occurring in the then apparent absence of risk factors may have been
overestimated. When the association of lipid abnormalities with increased risk of
coronary arterial disease was first recognized, "normality" of serum cholesterol was
based on results of measurements that were made in apparently healthy subjects.
Levels that were then accepted as normal would now be regarded as pathologically
high and a consequence of the excessively fatty diets and possibly resulting obesity
that has been all too common in western societies. As late as 1998, the CARE
study, an investigation of the effect of pravastatin (a cholesterol lowering medica-
tion) on the incidence of coronary events among survivors of a first myocardial
infarction was initiated because total serum cholesterol levels in the range of 5.2 to
6.2 mmol/L were then considered to be unproven as risk factors and therefore
regarded as normal. Indeed the ethical decision to allow randomizing halfthe study
population to placebo treatment was based on this premise. The term hyper-
cholesterolaemia was reserved for levels above 6.2 mmol/L. The results ofthe CARE
study itself showed that serum cholesterol concentrations earlier categorized as
"average" should now be considered pathologically high, even 5.2 mmol/L being
considered excessive.5
A measure of the incidence of overt coronary heart disease in populations with
total serum cholesterol levels that are acceptable as normal by present standards
5F M Sacksetal., 'Relationship betweenplasma LDLconcentrationsduringtreatmentwithpravastatin
and recurrent coronary events in the Cholesterol and Recurrent Events trial', Circulation, 1998, 15:
1446-52, p. 1447.
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